Global Serological Transplant Diagnostics Market 2017-2021 - Product Image

Global Serological Transplant Diagnostics Market 2017-2021

  • ID: 4307496
  • Report
  • Region: Global
  • 106 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Agena Bioscience
  • BD
  • Biogenuix
  • Grifols
  • Lorne Laboratories
  • Reagent Kft
  • MORE
About Serological Transplant Diagnostics

Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology. Donor and recipient cells, tissues, and organs should match or be compatible with the recipient's or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not accept. This can lead to the chronic rejection of organs.

The analysts forecast the global serological transplant diagnostics market to grow at a CAGR of 4.43% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global serological transplant diagnostics market for 2017-2021. To calculate the market size, the report considers sales, volume, and value of serological transplant diagnostics products.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Serological Transplant Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Bio-Rad Laboratories
- Immucor
- Siemens Healthineers
- Ortho Clinical Diagnostics
- Thermo Fisher Scientific

Other prominent vendors
- Agena Bioscience
- AVIOQ
- BAG Healthcare
- BD
- Beckman Coulter
- Biocell Medicare
- Biogenuix
- DIAGAST
- Grifols
- Hemo bioscience
- Institut de Biotechnologies
- Lorne Laboratories
- MTC INVITRO
- Quotient Biodiagnostics
- Reagent Kft
- Tulip Group

Market drivers
- Advancements in technology for organ transplantation
- For a full, detailed list, view the full report

Market challenges
- High cost of transplant and unfavorable reimbursement scenario
- For a full, detailed list, view the full report

Market trends
- Government initiatives for transplant research programs
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key Market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are theKey vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Agena Bioscience
  • BD
  • Biogenuix
  • Grifols
  • Lorne Laboratories
  • Reagent Kft
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Organ transplantation: Overview
PART 05: Market landscape
  • Overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Overview
  • Reagents and accessories
  • Systems
PART 07: Market segmentation by application
  • Overview
  • Kidney transplantation
  • Liver transplantation
  • Heart transplantation
  • Lung transplantation
  • Pancreas transplantation
  • Other transplantations
PART 08: Market segmentation by end-user
  • Hospitals, blood banks, and transplant centers
  • Donor registries and research laboratories
PART 09: Geographical segmentation
  • Overview
  • Americas
  • EMEA
  • APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Market challenges
PART 12: Market trends
  • Government initiatives for transplant research programs
  • Liquid biopsy as next generation transplantation diagnostics
  • Emergence of 3D bioprinting
PART 13: Vendor landscape
  • Competitive landscape
PART 14: Key vendor analysis
  • Bio-Rad Laboratories
  • Immucor
  • Siemens Healthineers
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Serological assays: Types
Exhibit 02: Living and deceased donors: Market impact analysis 2013
Exhibit 03: Global serological transplant diagnostics market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global serological transplant diagnostics market: Segmentation by product type 2016 ($ millions)
Exhibit 06: Serological transplant diagnostics reagents and accessories: Overview
Exhibit 07: Reagents and accessories 2016-2021 ($ millions)
Exhibit 08: Reagents and accessories: Market impact analysis
Exhibit 09: Systems: Market overview
Exhibit 10: Systems and software 2016-2021 ($ millions)
Exhibit 11: Systems: Market impact analysis
Exhibit 12: Global serological transplant diagnostics market: Segmentation by application 2016
Exhibit 13: Kidney transplantation: Market overview
Exhibit 14: Liver transplantation: Market overview
Exhibit 15: Heart transplantation: Market overview
Exhibit 16: Global serological transplant diagnostics market: Segmentation by end-user 2016
Exhibit 17: Buying criteria and impact analysis
Exhibit 18: Global serological transplant diagnostics market in 2016
Exhibit 19: Serological transplant diagnostics market in Americas: Overview
Exhibit 20: Serological transplant diagnostic market in Americas 2016-2021 ($ millions)
Exhibit 21: Serological transplant diagnostics market in Americas: Market analysis
Exhibit 22: Types and number of organ transplantation procedures performed in US 2015
Exhibit 23: Serological transplant diagnostic in US: Overview
Exhibit 24: Serological transplant diagnostic market in EMEA: Overview
Exhibit 25: Objectives and action plan of EU for organ transplantation in 2014
Exhibit 26: Serological transplant diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 27: Serological transplant diagnostics market in EMEA: Market analysis
Exhibit 28: Serological transplant diagnostics in UK: Overview
Exhibit 29: Serological transplant diagnostics market in APAC: Overview
Exhibit 30: Serological transplant diagnostic market in APAC 2016-2021 ($ millions)
Exhibit 31: Serological transplant diagnostics market in APAC: Market analysis
Exhibit 32: Serological transplant diagnostics in Australia: Overview
Exhibit 33: Technology advances: Market impact analysis
Exhibit 34: Number of M&As of hospitals in US 2010-2015
Exhibit 35: Average cost of transplantation procedures
Exhibit 36: People waiting for organ transplants 2016
Exhibit 37: Complications specific to organs
Exhibit 38: Legal and ethical issues in different countries
Exhibit 39: Government initiative for organ transplant research
Exhibit 40: Global serological transplant diagnostics market: Competitive structure analysis 2016
Exhibit 41: Global serological transplant diagnostics market: Competitive analysis 2016
Exhibit 42: Global serological transplant diagnostics market: Strategies for large and small companies
Exhibit 43: Bio-Rad Laboratories: Strength assessment
Exhibit 44: Bio-Rad Laboratories: Strategy assessment
Exhibit 45: Bio-Rad Laboratories: Opportunity assessment
Exhibit 46: Immucor: Strength assessment
Exhibit 47: Immucor: Strategy assessment
Exhibit 48: Immucor: Opportunity assessment
Exhibit 49: Siemens Healthineers: Strength assessment
Exhibit 50: Siemens Healthineers: Strategy assessment
Exhibit 51: Siemens Healthineers: Opportunity assessment
Exhibit 52: Ortho Clinical Diagnostic: Strength assessment
Exhibit 53: Ortho Clinical Diagnostic: Strategy assessment
Exhibit 54: Ortho Clinical Diagnostic: Opportunity assessment
Exhibit 55: Thermo Fisher Scientific: Strength assessment
Exhibit 56: Thermo Fisher Scientific: Strategy assessment
Exhibit 57: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Agena Bioscience
  • BD
  • Biogenuix
  • Grifols
  • Lorne Laboratories
  • Reagent Kft
  • MORE
New Report Released: – Global Serological Transplant Diagnostics Market 2017-2021

The author of the report recognizes the following companies as the key players in the global serological transplant diagnostics market: Bio-Rad Laboratories, Immucor, Siemens Healthineers, Ortho Clinical Diagnostics, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Agena Bioscience, AVIOQ, BAG Healthcare, BD, Beckman Coulter, Biocell Medicare, Biogenuix, DIAGAST, Grifols, Hemo bioscience, Institut de Biotechnologies, Lorne Laboratories, MTC INVITRO, Quotient Biodiagnostics, Reagent Kft, and Tulip Group.

Commenting on the report, an analyst from the research team said: “One trend in the market is government initiatives for transplant research programs. Governments worldwide have undertaken initiatives to reduce the waiting time for people seeking organ donors. They have provided funding to develop artificial organs and conduct R&D on transplants.”

According to the report, one driver in the market is advancements in technology for organ transplantation. The development of new and improved transplantation products such as tissue products, tissue typing technology, and surgical medical instruments drives the growth of the market. Advances in organ preservation have increased the efficiency of organs, which has led to a decrease in waiting time. In addition, vendors offer better and more efficient immunosuppressant drugs for transplant procedures.

Further, the report states that one challenge in the market is high cost of transplant and unfavorable reimbursement scenario. Expenses related to transplantation include the cost of organ, transplantation procedure cost, and transplant diagnostic cost. The high cost often discourages patients from opting for these procedures. Also, the diagnostic cost is hindering laboratories and hospitals from adopting high-cost sequencers. Further, the cost of the procedure and medication can lead to out-of-pocket expense, which is hindering the growth of the global serological transplant diagnostics market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Bio-Rad Laboratories
  • Immucor
  • Siemens Healthineers
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Agena Bioscience
  • AVIOQ
  • BAG Healthcare
  • BD
  • Beckman Coulter
  • Biocell Medicare
  • Biogenuix
  • DIAGAST
  • Grifols
  • Hemo bioscience
  • Institut de Biotechnologies
  • Lorne Laboratories
  • MTC INVITRO
  • Quotient Biodiagnostics
  • Reagent Kft
  • Tulip Group.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll